pargyline has been researched along with scopolamine hydrobromide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Avis, HH; Peeke, HV | 1 |
| Osman, OH | 1 |
| Morgane, PJ; Stern, WC | 1 |
| Bhargava, LP; Dandiya, PC | 1 |
| Pazzagli, A; Pepeu, G | 1 |
| Dringenberg, HC; Vanderwolf, CH | 1 |
| Dong, SN; Gong, Q; Li, J; Li, XK; Liu, WW; Mao, F; Tang, Y; Wang, H; Wang, TD; Xu, YX; Zhang, HY; Zhu, J | 1 |
1 review(s) available for pargyline and scopolamine hydrobromide
| Article | Year |
|---|---|
Theoretical view of REM sleep function: maintenance of catecholamine systems in the central nervous system.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain; Brain Chemistry; Catecholamines; Cats; Electroencephalography; Electroshock; Humans; Hydroxydopamines; Imipramine; Models, Biological; Nerve Tissue Proteins; Pargyline; Physostigmine; Rats; Reserpine; Scopolamine; Sleep Deprivation; Sleep, REM; Stress, Psychological | 1974 |
7 other study(ies) available for pargyline and scopolamine hydrobromide
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The effects of pargyline, scopolamine, and imipramine on territorial aggression in the convict cichlid (Cichlasoma nigrofasciatum).
Topics: Aggression; Animals; Drug Interactions; Fishes; Humans; Imipramine; Male; Pargyline; Scopolamine | 1979 |
Hypothermic response to intracerebral injection of scorpion venom in rats: role of brain catecholamines.
Topics: Animals; Body Temperature; Catecholamines; Cerebral Ventricles; Female; Fenclonine; Hydroxydopamines; Injections; Injections, Intraperitoneal; Methyltyrosines; Pargyline; Physostigmine; Rats; Scopolamine; Scorpions; Venoms | 1974 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine Oxidase Inhibitors; Nialamide; Nicotine; Nortropanes; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Physostigmine; Rats; Scopolamine; Sulfonic Acids; Tolazoline; Tremor; Tremorine; Trihexyphenidyl; Tryptamines | 1968 |
Amnesic properties of scopolamine and brain acetylcholine in the rat.
Topics: Acetylcholine; Amnesia; Amphetamine; Animals; Behavior, Animal; Brain; Humans; Pargyline; Physostigmine; Rats; Scopolamine | 1965 |
5-Hydroxytryptamine (5-HT) agonists: effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade.
Topics: Animals; Cerebral Cortex; Dose-Response Relationship, Drug; Male; Pargyline; Rats; Reserpine; Scopolamine; Serotonin Receptor Agonists | 1996 |
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Pyrimidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea | 2018 |